San Diego
September 25, 2024:
March 25, 2024: The Expanding Role of Pharma in our Ecosystem
Artie Suckow, CEO, DTx
Clare Ozawa, Partner, Versant Ventures
Dan Estes, Partner, Frazier Life Sciences
Kevin Forrest, CEO, Kate Therapeutics
Moderated by Aliza Apple, COO & Head of Lilly Gateway Labs West Coast, Lilly
September 27, 2023: Implications of the Inflation Reduction Act
Dina Lynch, Head of Market Access, Alzheon
Kevin Finney, CEO, Autobahn Therapeutics
Matt Wetzel, Partner, Life Sciences, Goodwin
Sarah Honig, VP, Corporate Development & Strategy, Tyra Biosciences
Moderated by Mark Spring, Managing Director, Danforth Advisors